本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Denali Therapeutics Inc.

24.93
+0.73003.02%
盤後24.930.00000.00%19:30 EDT
成交量:112.05萬
成交額:2,798.47萬
市值:39.85億
市盈率:-8.79
高:25.26
開:24.86
低:24.81
收:24.20
52周最高:27.30
52周最低:12.58
股本:1.60億
流通股本:1.51億
量比:1.07
換手率:0.74%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
淨資產收益率:-54.93%
總資產收益率:-29.15%
市淨率:4.77
市盈率(LYR):-8.39

資料載入中...

2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/10

重要事件披露

Form 8-K - Current report
2024/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities